Why should you receive treatment
for liver cancer in AMC ?
Liver cancer is a malignant tumor that often develops in patients with chronic liver diseases including hepatitis B, hepatitis C, and alcohol-induced liver diseases. Therefore, liver cancer patients generally suffer from chronic hepatitis or liver cirrhosis. Liver cancer is sometimes detected early through regular observations, but often it is found in a state of advanced cancer without symptoms. As previously mentioned, often times, it is accompanied by chronic liver diseases such as liver cirrhosis. Therefore, it is necessary to consider both diseases to decide on an optimal treatment plan. In some cases, it is also characterized by recurrence during the follow-up period even after treatment. For this reason, an appropriate treatment plan should be accustomed to each individual situation.
Liver cancer is treated solely or in conjunction with a hepatic resection, liver transplantation, radiofrequency ablation (RFA), percutaneous ethanol injection therapy (PEIT), transcatheter arterial chemoembolization (TACE), targeted therapy, chemotherapy, and radiotherapy. A treatment option is determined by collectively considering the location and size of the tumor, the stage, and the severity of the cirrhosis. Therefore, it is desirable to create an environment capable of accommodating a multidisciplinary approach, a consultation method where experienced medical professionals join together in a single location to provide the best treatment plan in communication and collaboration with various departments.
AMC Liver Cancer Center established a systematic treatment system that allows for liver cancer patients to receive optimal treatment in the best medical environment by improving medical treatment, streamlining the surgery process and surgical skill, reinforcing cooperation among departments, promoting regular meetings and studies, and carrying out high-quality researches.
The Liver Cancer Center provides fast reservations and referrals, allowing patients to see doctors of other specialties on the same day for fast diagnosis and treatment. The Center holds weekly multidisciplinary meetings to discuss and determine the best treatment option for complicated cases such as patients with liver cancer.
Living donor liver transplantation using a right lobe graft, living donor liver transplantation using a left lobe graft, living donor liver transplantation using a hepatic segment graft, and dual living donor liver transplantation
One of the surgical options mentioned above is decided on by considering various elements such as the patient’s condition, cancer stage, and liver function. Therefore, making an accurate diagnosis and identifying the patient’s condition are important in determining the best treatment option. This is possible through close cooperation with various departments.
AMC's treatment performance
-World-class living donor liver transplantation : more than 5,000
· The first and largest number of dual living donor liver transplantation in the world : 437
· The largest number of ABO-incompatible living donor liver transplantation in the world : 376
More than 800 hepatic resection performed per year
The largest number of procedures performed in Korea per year
· More than 4,300 transcatheter arterial chemoembolizations
· More than 600 radiofrequency ablations
· 700 radiotherapies
Excellent treatment results comparable to those of the most prestigious hospitals in the world
The Liver Cancer Center is recognized as the largest center for liver cancer treatment in Korea. It is visited by more than 1,700 new liver cancer patients every year. The center performed more than 800 hepatic resections, 400 liver transplantations (around 200 liver transplantations caused by liver cancer), 4,300 TACE, 600 RFA, and 700 radiotherapies annually.